Loading...
2
0
20
0
false
Full Name
Sabri, Nagwa
Type
Subject
- 1 Antiviral drugs | COVID-19 | SARS-CoV-2 | Signaling pathways | Signalome | Vaccines
- 1 Asymmetric dimethylarginine | Endothelial dysfunction | Febuxostat | Hemodialysis | Hyperuricemia | Inflammation
- 1 ATTITUDES
- 1 AWARENESS
- 1 BAP1 mutations | Circulating tumor cells | Immunohistochemistry | Malignant pleural mesothelioma | Overall clinical benefit | Overall survival | Progression free survival
- 1 BDNF-TrkB-CREB signaling pathway | CoQ10 | Phenytoin | Vascular endothelial growth factor (VEGF) | α-Toc
- 1 Bioequivalence | Chronopharmacology | Circadian rhythm | Diabetes Mellitus | Empagliflozin 10 mg | Evening dose | Morning dose | Pharmacodynamic | Pharmacokinetics
- 1 Breast cancer | Clinical pharmacist interventions | Quality of life | Toxicity grades
- 1 CABG | IL-6 | Ischemia/reperfusion injury | Melatonin | NF-kB | TNF-α | Troponins
- 1 Cannabis | Cytochrome P3A4 | Drug interactions | Erectile dysfunction | Oxidative stress | Pharmacodynamics | Pharmacokinetics | Safety | Sildenafil | Smokers
- < previous next >
Date issued
- 65 2000 - 2105
Fulltext
- 46 No Fulltext
- 19 With Fulltext
Results 61-65 of 65 (Search time: 0.0 seconds).